|
AU2015242981A1
|
|
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
|
|
AU2014218362A1
|
|
Human Monoclonal Antibodies to Activin Receptor-like Kinase-1
|
|
AU2014203036A1
|
|
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
|
|
AU2013242840A1
|
|
Antibodies Against T Cell Immunoglobulin Domain and Mucin Domain 1 (TIM-1) Antigen and Uses Thereof
|
|
AU2013224652A1
|
|
Antibodies Directed to Angiopoietin-like Protein 4 and Uses Thereof
|
|
AU2013205016A1
|
|
Human Monoclonal Antibodies to Activin Receptor-like Kinase-1
|
|
AU2012268864A1
|
|
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
|
|
AU2012216429A1
|
|
Antibodies to OPGL
|
|
AU2012213934A1
|
|
Antibodies against interleukin-1 beta
|
|
AU2012211512A1
|
|
Transgenic Mammals Having Human Ig Loci Including Plural Vh and Vk Regions and Antibodies Produced Therefrom
|
|
AU2012203432A1
|
|
Human Monoclonal Antibodies to Activin Receptor-like Kinase-1
|
|
AU2011265359A1
|
|
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
|
|
SG10201701323TA
|
|
Antibodies to ccr2
|
|
AU2008202860A1
|
|
Human Antibodies Derived From Immunized Xenomice
|
|
CN101808661A
|
|
anti-ige antibodies
|
|
AU2008200005A1
|
|
Transgenic Mammals Having Human Ig Loci Including Plural Vh and Vk Regions and Antibodies Produced Therefrom
|
|
TW200813091A
|
|
Targeted binding agents directed to uPAR and uses thereof
|
|
US2007065444A1
|
|
Human monoclonal antibodies to activin receptor-like kinase-1
|
|
US2006275292A1
|
|
Fully human anti-CD3 monoclonal antibodies
|
|
WO2006124269A2
|
|
Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders
|
